ArticleUltrasonography (Seoul, Korea)2025
Ultrasonography-assisted near-infrared spectroscopy imaging enhanced by gold nanorods in a xenograft mouse model of prostate cancer.
Article in Ultrasonography (Seoul, Korea), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study aimed to develop and evaluate a near-infrared spectroscopy (NIRS) system enhanced by gold nanorods (GNRs) for the detection of prostate cancer using phantom and xenograft mouse models.
methodsA hybrid ultrasound-NIRS (US-NIRS) system was created with a 785 nm wavelength, integrating eight laser diodes and four detectors with a linear ultrasound probe. Software for processing near-infrared (NIR) signals was developed using an engineering toolkit and an image reconstruction package. Two optical phantoms simulating prostate cancer were constructed using TiO2 for scattering effects and India ink for absorption effects, each containing a cylindrical cavity for GNRs positioned at depths of 1 cm and 2 cm. A xenograft mouse model was prepared by injecting PC-3 cells into the right flank of nude mice. PEGylated GNRs (GNR-PEG) were synthesized. US-NIRS imaging was performed on mice before and after intravenous injection of GNR-PEG.
resultsUltrasonography revealed solid, vascular tumors without necrosis or hemorrhage. Preinjection NIRS showed higher baseline NIR absorbance in tumors compared to normal tissue (optical depths: 0.26, 1.52, and 0.24 for the 1.5 cm, 1.4 cm, and 0.5 cm tumors, respectively). After GNR-PEG injection, tumor optical depths significantly increased (3.36, 4.39, and 1.69 for the 1.5 cm, 1.4 cm, and 0.5 cm tumors, respectively), peaking around 5 minutes, and subsequently decreasing towards baseline levels by 60 minutes.
conclusionA US-NIRS hybrid imaging system enhanced by GNR-PEG demonstrated increased NIR absorption in prostate cancer xenografts. This fusion imaging technique holds potential for future clinical applications in detecting prostate cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.